Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04901624 · ClinicalTrials.gov registry record · NA
Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 2,164
- Enrollment target
NCT04901624 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 2,164 participants.
The verdict
NCT04901624, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,164 participants
- Enrollment target
Study Summary
Repeat testing for SARS-CoV-2 antibodies in disadvantaged communities will help identify active and recovered infections over time, and as more is understood about antibody protection, it may help identify persons who have immunity. Many questions about social barriers and behavioral facilitators remain unanswered. This project aims to evaluate the effectiveness of risk-based messaging and incentives that promote repeated testing for SARS-CoV-2 antibodies, as well as to understand social and behavioral determinants of COVID-19 testing and variations within sub-groups of this population.
Interventions
- BEHAVIORAL Family Risk Messaging
- BEHAVIORAL Personal Risk Messaging
- BEHAVIORAL Loss Protection
- BEHAVIORAL Lottery Incentive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,164 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2023-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04901624
The ClinicalTrials.gov registry entry for NCT04901624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Family Risk Messaging is the first listed.
NCT04901624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04901624 about?
NCT04901624 is a clinical study titled "Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities". Repeat testing for SARS-CoV-2 antibodies in disadvantaged communities will help identify active and recovered infections over time, and as more is understood about antibody protection, it may help identify persons who have immunity. Many questions about social barriers and behavioral facilitators re...
What is the current status of trial NCT04901624?
This trial is currently completed. It is a NA study. The enrollment target is 2,164 participants. The study started on 2021-06-29. Estimated completion is 2023-06-03.
What interventions are being tested in trial NCT04901624?
The interventions under investigation include: Family Risk Messaging (BEHAVIORAL), Personal Risk Messaging (BEHAVIORAL), Loss Protection (BEHAVIORAL), Lottery Incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT04901624?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.